Cure8 research brief
Better delineation of dysplastic or neoplastic areas in ulcerative colitis can increase chances of complete endoscopic removal and help detect residual disease that white-light imaging misses.
Gastroenterologists/endoscopists performing UC surveillance and therapeutic ESD; patients with longstanding ulcerative colitis undergoing dysplasia surveillance; researchers studying endoscopic imaging or resection techniques.
This paper describes four UC patients in surveillance remission whose lesions had indistinct borders on white-light colonoscopy but became visible as crystal-violet–positive areas on targeted CV-SCAN. Biopsy confirmed neoplasia, CV-SCAN was repeated to map the lesion, and ESD was performed.
Three patients had en bloc curative resection; one required an additional ESD for residual disease identified again by CV-SCAN. No procedure-related adverse events or local recurrences were reported during follow-up. CV-SCAN is presented as an adjunct to, not a replacement for, existing endoscopic techniques.
The report is a small case series from a single center; it illustrates feasibility and potential usefulness in lesion delineation but does not establish comparative effectiveness or changed outcomes across broader populations.
This is an abstract-level case series (four patients) from a single report. Findings show feasibility but are not proof of broad effectiveness; larger controlled studies are needed. CV-SCAN is described as an adjunct to standard modalities.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The authors declare no conflicts of interest.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Better delineation of colitis‑associated neoplasia can improve the chance of complete endoscopic removal and help find residual disease that white‑light imaging may miss.
People with UC can develop severe neutrophilic skin complications like Sweet’s syndrome that may reflect active bowel inflammation even when recent tests suggested remission.
If confirmed, an endocytoscopic appearance that corresponds to a specific miRNA and chemokine pattern could help clinicians assess mucosal inflammation during colonoscopy and prioritize biopsies or treatment decisions...
